Research.Patient.info
Metastatic squamous cell carcinoma of head and neck research hub
2 indexed studies · 0 currently recruiting
- ongoing, recruitingPhase I and Phase II (Integrated)- Other
ABIMMUNE: A Phase I/II study evaluating the safety and clinical activity of anti-PDL1 (Durvalumab [MEDI4736]) + Anti CTLA-4 (Tremelimumab) antibodies administrated in combination with stereotactic body radiotherapy (SBRT) in patients with metastatic squamous cell carcinoma of head and neck, lung, oesophageus, cervix, vagina, vulva or anus.
This study looks at combining new cancer drugs with a special type of radiation for specific cancers that have spread. We want to see if this treatment is safe and if it helps shrink tumours. It's for certain cancers in the head, neck, lung, food pipe, and female private parts.
France - ongoing, recruitingPhase I and Phase II (Integrated)- First administration to humans
First-in-human interleukin-15-transpresenting Wilms’ tumor protein 1-targeting autologous dendritic cell vaccination in cancer patients
This study is testing a new vaccine for advanced cancers like pancreatic, liver, or ovarian cancer. It uses your own immune cells to create a special vaccine that targets cancer. This early study aims to see if the vaccine is safe, can be made successfully, and how it affects the cancer and your immune system.
Belgium